NR

Nagamallikharjuna Rao Maddi

Active Director Director DIN 08205477
DIN 08205477 First appointment Aug 2018 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Nagamallikharjuna Rao Maddi

Data last updated:

Nagamallikharjuna Rao Maddi is a Director at Honos Pharmaceuticals Private Limited (since 2018). The company operates in Food And Beverages.

DIN 08205477
Primary Designation Director
Industry Food And Beverages
First Appointment 23 Aug 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Aug 20182018Active

Board colleagues of Nagamallikharjuna Rao Maddi

NameDINCompanyDesignation
Sunitha Maddi08205478Honos Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Honos Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nagamallikharjuna Rao Maddi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagamallikharjuna Rao Maddi

Nagamallikharjuna Rao Maddi currently holds 1 directorship: Honos Pharmaceuticals Private Limited (Director, since 23 Aug 2018).

Nagamallikharjuna Rao Maddi was first appointed on 23 Aug 2018 as Director at Honos Pharmaceuticals Private Limited.

The current boards of Nagamallikharjuna Rao Maddi's companies include Sunitha Maddi (Honos Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available